Symbiosis offers a range of pharmaceutical product and process development services to support your assets from the pre-clinical phase into clinical trials. We can support from pre-manufacturing and beyond.
Establishing an end-to-end manufacturing process for your product is complex and challenging. Solving manufacturing challenges at one stage will often have an impact on subsequent manufacturing steps. A holistic approach to manufacturing, which includes addressing the issues faced in aseptic fill-finish will ensure that your project is de-risked and timelines are met.
We give you what you need – extensive experience in partnering with clients in early, pre-manufacturing stages of their journey to clinical trials.
Even at the later stages of manufacturing development, Symbiosis can help integrate and mitigate any changes upstream in the manufacturing process.
Symbiosis offers the following pre-clinical development services either directly or with the support of a network of trusted expert providers:
We have extensive experience in taking precious, complex drug products from manufacture to QP release.
Overcome your development and manufacturing challenges with a partner that has the experience and capabilities to handle your highly potent ADC
Clinical and small scale commercial manufacturing of advanced therapeutics such as viral vectors for cell and gene therapies, oncolytic viruses and critical raw materials such as plasmids.
Extensive experience in delivering hundreds of projects allowing us to support your clinical trials.
Symbiosis can support with challenging manufacturing and handling requirements that need specialist knowledge and experience.
Symbiosis has provided GMP manufacturing across a wide range of small molecule applications, including highly potent materials requiring specialist handling.